Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Oropharyngeal Neoplasms 2Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Medullary 1

Interventions

Magnetic Resonance Spectroscopy 18pembrolizumab 16Specimen Handling 15Cisplatin 14Carboplatin 9Platinum 8Cetuximab 81,2-diaminocyclohexaneplatinum II citrate 8Radiotherapy, Intensity-Modulated 7Radiation 7Paclitaxel 7Biopsy 7Taxes 6Radiotherapy 6cemiplimab 4X-Rays 4Standard of Care 4Nivolumab 4Drug Therapy 4(225)Ac-DOTA-c(RGDyK) 4durvalumab 3Ultrasonography 3Surgical Procedures, Operative 3Sentinel Lymph Node Biopsy 3Observation 3Immunoglobulin G 3Disulfides 3ipatasertib 2Watchful Waiting 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mouth Neoplasms × Neck Dissection × 1 year × Clear all
NCT04333537 2026-05-04

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

NRG Oncology

Phase 2/3 Recruiting
686 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡